CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES
Net income (loss)	$ 1,677	$ 1,304
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Impairment charges	56	86
Foreign exchange (gain) loss on net debt	(151)	(96)
Bad debt expense	8	23
Depreciation, depletion and amortization	317	305
Share-based compensation expense	51	47
Deferred income tax expense (benefit)	115	(92)
Results from affiliates	(100)	(95)
Other, net	57	80
Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:
Trade accounts receivable	306	(359)
Inventories	933	(229)
Secured advances to suppliers	(228)	26
Trade accounts payable and accrued liabilities	(690)	259
Advances on sales	(227)	(81)
Net unrealized (gains) losses on derivative contracts	(247)	(456)
Margin deposits	(111)	(55)
Recoverable and income taxes, net	(19)	(201)
Marketable securities	(17)	341
Beneficial interest in securitized trade receivables	0	(5,288)
Other, net	130	(550)
Cash provided by (used for) operating activities	1,860	(5,031)
INVESTING ACTIVITIES
Payments made for capital expenditures	(805)	(353)
Proceeds from investments	21	217
Payments for investments	(26)	(225)
Settlements of net investment hedges	(57)	(153)
Proceeds from beneficial interest in securitized trade receivables	85	5,176
Proceeds from disposals of businesses and property, plant and equipment	165	496
Payments for investments in affiliates	(136)	(55)
Other, net	107	10
Cash provided by (used for) investing activities	(646)	5,113
FINANCING ACTIVITIES
Net change in short-term debt with maturities of three months or less	161	842
Proceeds from short-term debt with maturities greater than three months	848	1,592
Repayments of short-term debt with maturities greater than three months	(593)	(1,600)
Proceeds from long-term debt	975	48
Repayments of long-term debt	(879)	(1,029)
Proceeds from the exercise of options for common shares	7	30
Repurchases of common shares	(466)	(200)
Dividends paid to common and preference shareholders	(287)	(256)
Capital contributions from (Return of capital to) noncontrolling interest	40	0
Sale of noncontrolling interest	0	521
Acquisition of redeemable noncontrolling interest and noncontrolling interest	0	(102)
Other, net	(19)	52
Cash provided by (used for) financing activities	(213)	(102)
Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale	40	112
Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale	1,041	92
Cash and cash equivalents, restricted cash, and cash held for sale - beginning of period	1,152	905
Cash and cash equivalents, restricted cash, and cash held for sale - end of period	$ 2,193	$ 997

BUNGELTD 10-Q